Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Actoplus Met XR (pioglitazone hydrochloride and metformin hydrochloride extended-release) fixed-dose combination tablets, 15mg/1000 mg and 30 mg/1000 mg
Company: Takeda Global Research & Development Center Inc.
Application No.: 022024
Approval Date: 5/12/2009

Persons with disabilities having problems accessing the PDF files below may call (301) 796-3634 for assistance.


Date created: March 25, 2010

Back to Top    Drugs@FDA

Vision impaired people having problems accessing certain pages of a PDF file may call (301) 796-3634 for assistance.

Note: Documents in PDF format require the Adobe Acrobat Reader®.